Gross Profit for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current gross profit (TTM) is $274.00M USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$274.00M
YoY change
-38.0%
5Y CAGR
+7.1%
Peak year (2021)
$15.12B
Cumulative gross profit
$34.73B
Gross Profit history chart for Moderna (MRNA) from 2016 to 2025
Gross Profit history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $1.08B | -38.0% | ||
| 2024 | $1.74B | -19.5% | ||
| 2023 | $2.15B | -84.0% | ||
| 2022 | $13.46B | -11.0% | ||
| 2021 | $15.12B | +1878.4% | ||
| 2020 | $764.21M | +2518.2% | ||
| 2019 | $29.19M | -73.5% | ||
| 2018 | $110.21M | -40.5% | ||
| 2017 | $185.29M | +98.6% | ||
| 2016 | $93.28M | — |
Gross Profit values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Moderna (MRNA) reported gross profit of $1.08B – plunged 38.0% year-over-year.
Moderna gross profit compound annual growth for the 2020–2025 (5 years) window is +7.1%, with the latest reading among the more recent periods of the dataset.
Moderna gross profit plunged from $15.12B in 2021 to $1.08B in 2025, a 92.9% drawdown.
The dataset's maximum gross profit sits at $15.12B (2021); the minimum reading of $29.19M dates to 2019.
Moderna (MRNA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $53.80B.
Moderna Gross Profit by Year
Moderna Gross Profit 2025: $1.08B
Moderna gross profit in 2025 was $1.08B, plunged 38.0% below 2024.
Moderna Gross Profit 2024: $1.74B
Moderna gross profit in 2024 was $1.74B, declined 19.5% below 2023.
Moderna Gross Profit 2023: $2.15B
Moderna gross profit in 2023 was $2.15B, plunged 84.0% below 2022.
Moderna Gross Profit 2022: $13.46B
Moderna gross profit in 2022 was $13.46B, declined 11.0% below 2021.
Moderna Gross Profit 2021: $15.12B
Moderna gross profit in 2021 was $15.12B.
See more financial history for Moderna (MRNA).
Sector peers — Gross Profit
Companies in the same sector as Moderna, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Moderna's gross profit?
- Latest reported gross profit for Moderna (MRNA) is $274.00M (period ending December 31, 2025).
How has Moderna gross profit changed year-over-year?
- Moderna (MRNA) gross profit changed -38.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna gross profit?
- Moderna (MRNA) gross profit compound annual growth rate is +7.1% over the most recent 5 years available.
When did Moderna gross profit hit its highest annual value?
- Moderna gross profit reached its highest annual value of $15.12B in 2021.
What was Moderna gross profit in 2024?
- Moderna (MRNA) gross profit in 2024 was $1.74B.
What was Moderna gross profit in 2025?
- Moderna (MRNA) gross profit in 2025 was $1.08B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.